SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-034672
Filing Date
2024-03-21
Accepted
2024-03-21 16:05:37
Documents
71
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K inkt-20231231.htm   iXBRL 10-K 1873429
2 EX-4.2 inkt-ex4_2.htm EX-4.2 88044
3 EX-10.18 inkt-ex10_18.htm EX-10.18 99814
4 EX-21.1 inkt-ex21_1.htm EX-21.1 6174
5 EX-23.1 inkt-ex23_1.htm EX-23.1 3150
6 EX-31.1 inkt-ex31_1.htm EX-31.1 15066
7 EX-31.2 inkt-ex31_2.htm EX-31.2 15037
8 EX-32.1 inkt-ex32_1.htm EX-32.1 8623
9 EX-32.2 inkt-ex32_2.htm EX-32.2 8586
10 EX-97.1 inkt-ex97_1.htm EX-97.1 46024
11 GRAPHIC img206969693_0.jpg GRAPHIC 27781
12 GRAPHIC img206969693_1.jpg GRAPHIC 37558
13 GRAPHIC img206969693_2.jpg GRAPHIC 47334
14 GRAPHIC img206969693_3.jpg GRAPHIC 26670
  Complete submission text file 0000950170-24-034672.txt   7035514

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT inkt-20231231.xsd EX-101.SCH 1023741
75 EXTRACTED XBRL INSTANCE DOCUMENT inkt-20231231_htm.xml XML 737171
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40908 | Film No.: 24771299
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)